搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
ENDPOINTS NEWS
15 小时
A Q&A with a Nobel Prize winner; Pfizer meets with Starboard; J&J reports Q3 earn ...
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday ...
ENDPOINTS NEWS
1 天
NJ judge tosses Novartis' IRA lawsuit another win for government
Novartis has lost its legal challenge against the Inflation Reduction Act on Friday, making it the sixth drugmaker rejected ...
ENDPOINTS NEWS
1 天
Lykos is optimistic about MDMA treatment after meeting with FDA
Lykos Therapeutics said it had a “productive” meeting with the FDA to discuss a path forward for its recently rejected PTSD ...
ENDPOINTS NEWS
1 天
FDA won't take action against GLP-1 compounders as it rethinks tirzepatide shortage
The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...
ENDPOINTS NEWS
1 天
Apertura and Atalanta reduce headcount en route toward the clinic
Two central nervous system disorder biotechs laid off employees recently. New York gene therapy startup Apertura and Boston ...
ENDPOINTS NEWS
1 天
FDA approves Astellas' gastric cancer drug Vyloy ahead of schedule
The FDA on Friday approved Astellas’ treatment for a type of gastric cancer, marketed as Vyloy (zolbetuximab). The approval ...
ENDPOINTS NEWS
1 天
EMA again recommends against authorization for PTC Therapeutics' Translarna
The European Medicines Agency’s human medicines committee again decided not to recommend the renewal of the conditional ...
ENDPOINTS NEWS
1 天
European Commission to work more closely with European Medicines Agency
The European Commission said Friday that it has officially adopted a new regulation explaining how it will cooperate more ...
ENDPOINTS NEWS
1 天
Gilead pulls Trodelvy's accelerated label in bladder cancer after drug ...
Gilead is withdrawing the accelerated approval for its blockbuster antibody-drug conjugate Trodelvy for bladder cancer after ...
ENDPOINTS NEWS
1 天
Pfizer ends trial of Array-acquired SHP2 inhibitor after similar cuts from ...
Pfizer has ended its trial of an SHP2 inhibitor that was being developed in cancer, the latest blow to the target after ...
ENDPOINTS NEWS
1 天
CVS replaces CEO Karen Lynch with PBM exec David Joyner
CVS Health is parting ways with CEO Karen Lynch as the pharmacy giant continues to struggle with problems in its insurance ...
ENDPOINTS NEWS
1 天
Supernus’ depression drug shows ‘rapid’ onset in mid-stage test
Supernus Pharmaceuticals' mTORC1 activator has cleared a small trial in patients with major depressive disorder, potentially ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈